Global Vasomotor Symptoms of Menopause Treatment Market By Product Type (Estetrol, Fezolinetant) And By End-Users/Application (Hospital, Homecare) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Vasomotor Symptoms of Menopause Treatment market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Vasomotor Symptoms of Menopause Treatment market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Vasomotor Symptoms of Menopause Treatment industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Vasomotor Symptoms of Menopause Treatment ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Vasomotor Symptoms of Menopause Treatment market.

The following manufacturers are covered in this report:
  • Amgen Inc.
  • EndoCeutics, Inc.
  • Euroscreen S.A.
  • MenoGeniX, Inc.
  • Mithra Pharmaceuticals S.A.
  • Pherin Pharmaceuticals, Inc.
  • Pivot Pharmaceuticals Inc
  • Radius Health, Inc.
  • TherapeuticsMD, Inc.

The report estimates on the Vasomotor Symptoms of Menopause Treatment market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Vasomotor Symptoms of Menopause Treatment market report consist of all leading industry players, Vasomotor Symptoms of Menopause Treatment business sections, company profile, revenue supply by Vasomotor Symptoms of Menopause Treatment industry sections, global Vasomotor Symptoms of Menopause Treatment market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Vasomotor Symptoms of Menopause Treatment market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Vasomotor Symptoms of Menopause Treatment market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Vasomotor Symptoms of Menopause Treatment market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Vasomotor Symptoms of Menopause Treatment market.

Report Opportunity: Global Vasomotor Symptoms of Menopause Treatment Market

This report delivers an analytical examination of the Vasomotor Symptoms of Menopause Treatment market summarized in broad sections such as
  1. Vasomotor Symptoms of Menopause Treatment Market Summary
  2. Key Commercial Growths in the Vasomotor Symptoms of Menopause Treatment Industry
  3. Market Dynamics Affecting the Vasomotor Symptoms of Menopause Treatment Industry
  4. Important Market Trends and Future Development Scenario of the Vasomotor Symptoms of Menopause Treatment Market
  5. Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Vasomotor Symptoms of Menopause Treatment Industry
  7. Positioning of Main Market Players in the Vasomotor Symptoms of Menopause Treatment Industry
  8. Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast, by Application, 2018 - 2028
  9. Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast, by Geography, 2018 - 2028
Vasomotor Symptoms of Menopause Treatment Market Segmentation:

The report provides detailed examination of the Vasomotor Symptoms of Menopause Treatment market on the basis of various segments such as type, application and end-use industry. The Vasomotor Symptoms of Menopause Treatment market is segmented as follows:

Vasomotor Symptoms of Menopause Treatment Market, by Type:
  • Estetrol
  • Fezolinetant
  • FP-101
  • HBN-2
  • Others
Vasomotor Symptoms of Menopause Treatment Market, by Application:
  • Hospital
  • Homecare
  • Clinic
Geographic Coverage

The report on the Vasomotor Symptoms of Menopause Treatment market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast
  • U.S.
  • Canada
Europe Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Vasomotor Symptoms of Menopause Treatment Market Snapshot
          2.1.1. Global Vasomotor Symptoms of Menopause Treatment Market By Type,2019
               2.1.1.1.Estetrol
               2.1.1.2.Fezolinetant
               2.1.1.3.FP-101
               2.1.1.4.HBN-2
               2.1.1.5.Others
          2.1.2. Global Vasomotor Symptoms of Menopause Treatment Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Homecare
               2.1.2.3.Clinic
          2.1.3. Global Vasomotor Symptoms of Menopause Treatment Market By End-use,2019
          2.1.4. Global Vasomotor Symptoms of Menopause Treatment Market By Geography,2019

3. Global Vasomotor Symptoms of Menopause Treatment Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028

5. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028

6. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028

7. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Vasomotor Symptoms of Menopause Treatment Market Analysis, 2018 – 2028 
          7.2.1. North America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Vasomotor Symptoms of Menopause Treatment Market Analysis, 2018 – 2028 
          7.3.1.  Europe Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Vasomotor Symptoms of Menopause Treatment Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Vasomotor Symptoms of Menopause Treatment Market Analysis, 2018 – 2028 
          7.6.1.  MEA Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Vasomotor Symptoms of Menopause Treatment Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Vasomotor Symptoms of Menopause Treatment Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Vasomotor Symptoms of Menopause Treatment Providers
        8.4.1 Amgen Inc.
                8.1.1 Business Description
                8.1.2 Amgen Inc. Geographic Operations
                8.1.3 Amgen Inc. Financial Information
                8.1.4 Amgen Inc. Product Positions/Portfolio
                8.1.5 Amgen Inc. Key Developments
        8.4.2 EndoCeutics, Inc.
                8.2.1 Business Description
                8.2.2 EndoCeutics, Inc. Geographic Operations
                8.2.3 EndoCeutics, Inc. Financial Information
                8.2.4 EndoCeutics, Inc. Product Positions/Portfolio
                8.2.5 EndoCeutics, Inc. Key Developments
        8.4.3 Euroscreen S.A.
                8.3.1 Business Description
                8.3.2 Euroscreen S.A. Geographic Operations
                8.3.3 Euroscreen S.A. Financial Information
                8.3.4 Euroscreen S.A. Product Positions/Portfolio
                8.3.5 Euroscreen S.A. Key Developments
        8.4.4 MenoGeniX, Inc.
                8.4.1 Business Description
                8.4.2 MenoGeniX, Inc. Geographic Operations
                8.4.3 MenoGeniX, Inc. Financial Information
                8.4.4 MenoGeniX, Inc. Product Positions/Portfolio
                8.4.5 MenoGeniX, Inc. Key Developments
        8.4.5 Mithra Pharmaceuticals S.A.
                8.5.1 Business Description
                8.5.2 Mithra Pharmaceuticals S.A. Geographic Operations
                8.5.3 Mithra Pharmaceuticals S.A. Financial Information
                8.5.4 Mithra Pharmaceuticals S.A. Product Positions/Portfolio
                8.5.5 Mithra Pharmaceuticals S.A. Key Developments
        8.4.6 Pherin Pharmaceuticals, Inc.
                8.6.1 Business Description
                8.6.2 Pherin Pharmaceuticals, Inc. Geographic Operations
                8.6.3 Pherin Pharmaceuticals, Inc. Financial Information
                8.6.4 Pherin Pharmaceuticals, Inc. Product Positions/Portfolio
                8.6.5 Pherin Pharmaceuticals, Inc. Key Developments
        8.4.7 Pivot Pharmaceuticals Inc
                8.7.1 Business Description
                8.7.2 Pivot Pharmaceuticals Inc Geographic Operations
                8.7.3 Pivot Pharmaceuticals Inc Financial Information
                8.7.4 Pivot Pharmaceuticals Inc Product Positions/Portfolio
                8.7.5 Pivot Pharmaceuticals Inc Key Developments
        8.4.8 Radius Health, Inc.
                8.8.1 Business Description
                8.8.2 Radius Health, Inc. Geographic Operations
                8.8.3 Radius Health, Inc. Financial Information
                8.8.4 Radius Health, Inc. Product Positions/Portfolio
                8.8.5 Radius Health, Inc. Key Developments
        8.4.9 TherapeuticsMD, Inc.
                8.9.1 Business Description
                8.9.2 TherapeuticsMD, Inc. Geographic Operations
                8.9.3 TherapeuticsMD, Inc. Financial Information
                8.9.4 TherapeuticsMD, Inc. Product Positions/Portfolio
                8.9.5 TherapeuticsMD, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Vasomotor Symptoms of Menopause Treatment Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Vasomotor Symptoms of Menopause Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Vasomotor Symptoms of Menopause Treatment Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Vasomotor Symptoms of Menopause Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Vasomotor Symptoms of Menopause Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Vasomotor Symptoms of Menopause Treatment Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Vasomotor Symptoms of Menopause Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Vasomotor Symptoms of Menopause Treatment Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Vasomotor Symptoms of Menopause Treatment Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Vasomotor Symptoms of Menopause Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Vasomotor Symptoms of Menopause Treatment: Market Segmentation 
FIG. 2 Global Vasomotor Symptoms of Menopause Treatment Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Vasomotor Symptoms of Menopause Treatment Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Vasomotor Symptoms of Menopause Treatment Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Vasomotor Symptoms of Menopause Treatment Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Vasomotor Symptoms of Menopause Treatment Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Vasomotor Symptoms of Menopause Treatment Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Vasomotor Symptoms of Menopause Treatment Providers, 2019
FIG. 11 Global Vasomotor Symptoms of Menopause Treatment Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Vasomotor Symptoms of Menopause Treatment Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Vasomotor Symptoms of Menopause Treatment Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Vasomotor Symptoms of Menopause Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Vasomotor Symptoms of Menopause Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Vasomotor Symptoms of Menopause Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Vasomotor Symptoms of Menopause Treatment Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Vasomotor Symptoms of Menopause Treatment Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Vasomotor Symptoms of Menopause Treatment market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1229

1990

OUR CLIENT